INTRODUCTION
============

Takayasu arteritis (TA) is a chronic inflammatory condition of unknown cause that involves large and medium caliber arteries, including the aorta and its main branches, and the coronary and pulmonary arteries.[@B1] ^,^ [@B2] ^,^ [@B5] TA is seen more commonly in individuals of Asian descent, aged between 10 and 30 years, and females (80-90%). Incidence in the USA and Europe ranges from 1 to 3 cases per million population a year.[@B15]

Transmural granulomatous inflammation characteristically seen in TA may cause stenosis, occlusion, dilation, and/or the formation of aneurysms in the involved arteries.[@B4] ^,^ [@B12] Genetic causes, infectious agents, and autoimmune factors may be connected to the progression of TA, in addition to a possible link between TA and infection by *Mycobacterium tuberculosis* (MT) as indicated in tuberculin purified protein derivative (PPD) tests.[@B10] ^,^ [@B12] The insidious onset of TA often means patients are diagnosed at later stages of the disease. Progression is divided into three stages: the first revolves around systemic involvement, in which patients present with unspecific signs lasting for weeks and even months, usually left unchecked; the second stage consists of inflammation of the vessels, leading to stenosis or the formation of aneurysms; the third stage, also known as fibrotic/late-stage disease, includes manifestations resulting from limb or organ ischemia due to the narrowing or obstruction of large vessels.[@B7] ^,^ [@B17]

TA is diagnosed based on the criteria set out by the American College of Rheumatology, which include the following: age 40 or younger at the onset of symptoms; claudication of an extremity; decreased brachial artery pulse; \> 10 mmHg difference in systolic blood pressure between arms; a bruit over the subclavian arteries or the aorta; and arteriographic evidence of narrowing of occlusion of the entire aorta, its primary branches, or large arteries in the proximal upper of lower extremities. The presence of three or more of these criteria confirm the diagnosis of TA with specificity and sensitivity above 90%.[@B3] ^,^ [@B8] ^,^ [@B12]

Treatment must be initiated with glucocorticoids 1-2 mg/kg/day for one to three months, followed by gradual decreases in dosage after 30 days combined with immunosuppressant therapy, with methotrexate as the first choice followed by azathioprine and mycophenolate mofetil; cyclophosphamide and infliximab are spared for severe and refractory cases.[@B4] ^,^ [@B7]

The specific effects of renal artery stenosis on the survival of patients with TA have not been described, since most studies focused on brachiocephalic involvement. However, severe hypertension is a known independent predictor of premature death and greater risk of adverse events in individuals with TA, leading to 5-year survival rates below 60%.[@B7]

CASE REPORT
===========

A 15-year-old unmarried female student and Jehovah's witness born and residing in Fortaleza, Ceará, Brazil, arrived at our unit complaining of myalgia, asthenia, and lower back pain irradiating toward her left leg lasting for a year. Her pain had been managed with dipyrone and ibuprofen. The patient reported having intense holocranial headaches associated with nausea and vomiting for six months. She sought care several times at emergency services. Her symptoms were treated in isolation and she was diagnosed as having migraines and anxiety, which led to a prescription of fluoxetine 20 mg/day. She took the prescribed medication for six months, but her symptoms never subsided. A month prior to being hospitalized she had a dry cough and pleurisy associated with orthopnea and paroxysmal nocturnal dyspnea, which prompted her to seek care. Physical examination revealed she was tachypneic, with low oxygen saturation levels on pulse oximetry, and increased blood pressure (BP) (200/120 mmHg). Lung auscultation revealed she had diffuse bilateral crackles. She did not improve after initial measures, which included oxygen therapy, morphine, nitrate, and diuretics, and progressed to acute respiratory failure. The patient was then intubated and placed on a ventilator.

She was referred to the intensive care unit at Hospital Infantil Albert Sabin with anuria and signs of pulmonary edema. Her tests on admission showed high levels of nitrogenous wastes, and she was prescribed hemodialysis. Physical examination showed her right brachial artery pulse was decreased and a difference greater than 10 mmHg in BP between arms. The patient denied she had had previous diseases or hospitalizations. She had a family history of anxiety disorder (her mother and brother) and a cousin with pulmonary tuberculosis. After a few hemodialysis sessions with ultrafiltration, her respiratory condition improved and she was sent to a ward, although she still presented with difficult-to-control hypertension, anuria, hypercatabolism, repeated episodes of acute pulmonary edema, and indication for daily hemodialysis.

Her workup showed she had iron-deficiency anemia, increased C-reactive protein (CRP) levels, and an elevated erythrocyte sedimentation rate (ESR) ([Table 1](#t1){ref-type="table"}); transaminase levels and thyroid function were within normal range. Serology tests for hepatitis B, C, HIV, toxoplasmosis, cytomegalovirus, parvovirus, EBV, and syphilis were negative. A transthoracic echocardiogram revealed she had diffuse hypokinesis and a moderately dilated and dysfunctional left ventricle with an ejection fraction of 42%. No alterations were seen in the Doppler ultrasound examination of the carotid and vertebral arteries. Tests for ANA, lupus anticoagulant, anticardiolipin antibodies, anticentromere antibodies, anti-Scl 70 antibodies, antineutrophil cytoplasmic antibodies (ANCA), anti-Ro/SSA and anti-La/SSB antibodies, anti-Sm antibodies, and anti-DNA antibodies were negative; anti-β2 glycoprotein I IgM and IgG antibodies were negative; CH50, C3, and C4 were normal. Demonstration of AARB (gastric lavage) was negative. The PPD skin test read 14 mm of induration.

###### Laboratory workup

  ----------------------- ------ ----------------------------- ----------
  Hemoglobin (mg/dL)      9.4    Urea (mg/dL)                  120
  Hematocrit (%)          29.3   Creatinine (mg/dL)            3.5
  MCV (fL)                78     ESR (mm)                      52
  MCHC (g/dL)             32.1   CRP (mg/L)                    132
  Leukocytes (/mm^3^)     9200   LDH                           935
  Segmented (%)           63     Direct Coombs                 negative
  Rod (%)                 0      PTH (pg/mL)                   13.2
  Lymphocytes (%)         29     25-hydroxyvitamin D (ng/mL)   23.2
  Platelets (mil/mm^3^)   365    Total bilirubin               0.33
  Iron                    6      Direct bilirubin              0.05
  Transferrin sat. (%)    21.3   Albumin (mg/dL)               3.9
  ----------------------- ------ ----------------------------- ----------

Multi-slice computed tomography angiography of the chest showed nodular opacity on the upper lobe of the left lung without vascular alterations. Initial ultrasound examination of the urinary pathways showed kidneys with a normal structural pattern and location; the right kidney measured 9.3 x 4.7 x 4.1 cm with a parenchymal thickness of 14.3 mm; the left kidney measured 9.0 x 4.3 x 4.3 cm with a parenchymal thickness of 16.4 mm. Doppler flowmetry showed normal peaks of systolic and diastolic velocity and resistive index. Multi-slice computed tomography angiography of the abdominal aorta showed absence of flow in the proximal segments of the two renal arteries ([Figure 1](#f1){ref-type="fig"}) indicating stenosis/occlusion; multiple sites with focal luminal narrowing and sites with segmental dilatation in the area where the celiac trunk emerges and in the proximal third of the superior mesenteric artery; and minor segmental luminal narrowing of the abdominal aorta in the infrarenal area 6.0 cm from the celiac trunk. Large- and medium-vessel vasculitis indicated the presence of Takayasu arteritis.

Figure 1Multi-slice computed tomography angiography of the abdominal aorta showing absence of flow in the renal arteries.

A kidney biopsy performed on day 30 of hospitalization showed 13 glomeruli characterized as normal, global glomerulosclerosis (1/13), focal tubular atrophy with mild interstitial fibrosis, and negative immunofluorescence ([Figures 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"}).

Figure 2Optical microscopy image of a PAS-stained kidney biopsy specimen, 400x magnification: glomerulus with conserved cellularity and regular capillary loops.

Figure 3Optical microscopy image of a Jones Silver-stained kidney biopsy specimen, 400x magnification: capillary loops with regular contours.

The patient was started on pulse therapy with methylprednisolone 1 g for three days followed by oral prednisone 60 mg/day. Due to the severity of her vascular involvement, she was prescribed cyclophosphamide and prophylactic isoniazid for tuberculosis. Revascularization was not indicated on account of disease activity and because she refused blood transfusions for religious reasons. Another biopsy was performed (six months after the onset of anuria) and the results showed 14 glomeruli with diffuse ischemic glomerular retraction, degenerative tubule epithelial cell alterations with signs of atrophy and moderate interstitial fibrosis, and multifocal tubulointerstitial nephritis, with negative immunofluorescence ([Figures 4](#f4){ref-type="fig"} and [5](#f5){ref-type="fig"}). The choice was made for conservative management on account of signs consistent with chronic kidney disease and the time of progression of the disease.

Figure 4Optical microscopy image of a PAS-stained kidney biopsy specimen, 100x magnification: glomerulus with retracted tuft and relatively increased urinary space.

Figure 5Optical microscopy image of a Jones Silver-stained kidney biopsy specimen, 400x magnification: retracted, tortuous capillary loops.

After a year on hemodialysis, the patient underwent a deceased-donor kidney transplant at Hospital Geral de Fortaleza. She was prescribed thymoglobulin for induction immunosuppression therapy and tacrolimus, everolimus, and prednisone for maintenance therapy. She progressed satisfactorily and was on fewer antihypertensive drugs and improved cardiac function as shown by normal electrocardiograms a year after transplantation. Her final creatinine level was 0.7 mg/dL.

DISCUSSION
==========

TA was described for the first time in 1908 by the Japanese ophthalmologist Mikito Takayasu, who reported the case of a 21-year-old young woman with sudden loss of eyesight, arteriovenous anastomoses around the optic disc, and no radial pulse.[@B2] ^,^ [@B7] In recent years, an association has been described between TA and infection by MT. Clemente et al. described positive tuberculosis tests in 43.1% of the individuals included in a study. Our patient had a latent infection by MT evinced by a 14-mm induration on the PPD test and nodular opacity in the upper lobe of the left lung, in addition to positive epidemiology.[@B11]

Studies carried out in Asia found that renal artery injury associated with TA including dilatation, aneurysm, and stenosis, was reported in 30-35% of the cases. Stenosis accounted for the majority of these injuries with 23-31% of the cases.[@B5] The progression of stenosis is directly linked to worsening hypertension and deterioration of renal function secondary to ischemic renal disease. Therefore, renal artery stenosis is an important prognostic factor for TA.[@B9]

The patient described in this report met four of the criteria for TA, had had constitutional symptoms for a year, and presented severe complications such as difficult-to-control hypertension, cardiac dysfunction, and acute kidney injury requiring dialysis, all of which indicative of renal hypertension. Renal hypertension - defined by the combination of hypertension and significant stenosis of the renal artery - is the main potentially curable cause of high blood pressure. By frequency of occurrence, the main etiologies are atherosclerosis and fibromuscular dysplasia, followed by other less common causes such as TA. Patients with severe refractory hypertension, hypertension starting before 20 or after 50 years of age, and hypertension associated with renal failure must be suspected for renal hypertension.[@B6] ^,^ [@B14]

Prolonged ischemia leads to gradual atrophy and loss of kidney structural integrity. The parameters around the minimum amount of stenosis required for the onset of renal ischemia have not been established, but stenosis involving more than 75% of the diameter of the renal artery has been associated with poorer outcomes. Few studies have examined the structural and functional effects of chronic decreases of perfusion pressure on renal tissue after vascular stenosis. Renal ischemia causes the release of cytokines, which by their turn trigger immune and inflammatory responses. The perpetuation of this mechanism induces renal fibrosis, with glomerular hyalinization and progressive kidney atrophy.[@B18]

Renovascular disease may be treated clinically, surgically, or by percutaneous procedures (with or without stent grafts). Calcium channel blockers, angiotensin-converting-enzyme inhibitors, angiotensin II type 1 receptor blockers, and beta blockers have been effectively used to treat systemic hypertension associated with renal artery stenosis. Percutaneous procedures or revascularization surgery are indicated in cases of resistant, accelerated, or malignant hypertension; progressive loss of renal function with bilateral stenosis or stenosis in individuals with one kidney; congestive heart failure or repeated episodes of acute pulmonary edema.[@B6] ^,^ [@B16]

Endovascular approaches such as angioplasty with or without stenting and revascularization surgery may be employed in individuals with critical stenosis, but these procedures should be carried out only after the patient has been in remission, since negative outcomes may occur in individuals with active disease.[@B10] ^,^ [@B15] Recent publications on renovascular disease associated with TA have included few subjects given the low prevalence of this condition. The evidence available indicates renal angioplasty has yielded better outcomes. The immediate outcome of angioplasty is generally good, but sustaining vascular patency relies on the good management of the disease's inflammatory activity.[@B15] Treatment failure occurs primarily in cases of involvement of the aorta associated with proximal renal artery involvement.[@B6]

Similarly to our case, Tumeleiro et al. reported on a 25-year-old patient presented with vomiting, headaches, acute pulmonary edema, hypertension (200/140 mmHg), mildly increased creatinine level, and cardiac dysfunction. Her arteriogram revealed a 60% obstruction on the ostium of the right renal artery and severe obstruction on the ostium of the left renal artery. She had stents placed in her renal arteries (initially on the left renal artery and three years later on her right renal artery when she had an 80% obstruction) and evolved well to fewer clinical and echocardiogram signs of aortic regurgitation, normal creatinine levels, controlled BP (140/60 mmHg), and prescription of fewer antihypertensive drugs.[@B13]

This report described the case of a 15-year-old female with severe acute kidney injury, difficult-to-control hypertension, and cardiac dysfunction secondary to stenosis of the renal arteries by TA. Surgery was contraindicated at first for reasons of disease activity and severe anemia. After she became clinically stable, ultrasound examination of the urinary pathways and kidney biopsy revealed she had progressed to chronic kidney disease.
